Key Factors That Drive and Impede The Growth of Oligonucleotide Synthesis Market 2022 – 2027
https://bit.ly/3hQ6RgU
The report "Oligonucleotide Synthesis Market by Product (Drug, Synthesized Oligo (Primer), Reagents), Type (Custom, Predesigned), Application (Therapeutic (ASO, siRNA), Research ((PCR, Sequencing, Diagnostics)), End User (Pharma, CROS, CMOs) - Global Forecast to 2027", is projected to reach USD 16.7 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 16.8% during the forecast period. One of the key factors driving the market growth is the emerging field of personalized genome sequencing, which helps determine the best approach for patient care, whether preventive, diagnostic, or therapeutic. The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.
https://bit.ly/3hQ6RgU
The report "Oligonucleotide Synthesis Market by Product (Drug, Synthesized Oligo (Primer), Reagents), Type (Custom, Predesigned), Application (Therapeutic (ASO, siRNA), Research ((PCR, Sequencing, Diagnostics)), End User (Pharma, CROS, CMOs) - Global Forecast to 2027", is projected to reach USD 16.7 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 16.8% during the forecast period. One of the key factors driving the market growth is the emerging field of personalized genome sequencing, which helps determine the best approach for patient care, whether preventive, diagnostic, or therapeutic. The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.
